The emerging approach of the medication represents a exciting development in the management of the condition. Different to existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – leading https://tirzepatidepeptide399405.gynoblog.com/40714322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment